Facing Tougher Competition At Home, China's Mindray Should Target Global Mid- To High-end Market, Analysts Say
This article was originally published in PharmAsia News
Executive Summary
Facing a new round of marketing campaigns from international device makers targeting China's low- to mid-end hospital markets, Shenzhen based Mindray Medical will be better off focusing instead on mid- to high-end global markets to stay competitive, analysts say
You may also be interested in...
A Closer Look: Changes To China’s Orthopedics Market Fuel Deals Like Stryker-Trauson
Large domestic players like Trauson could benefit from new guidelines mandating centralized purchases for high-value medical consumables.
China's Leading Device Maker Mindray Projects Strong Earnings Despite Instability Across The Middle East
BEIJING - Despite instability in the Middle East and North Africa, the leadership of Mindray Medical International is pressing ahead with plans to expand sales in international markets and is projecting a rise in net earnings of more than 10% in 2011
China's Leading Device Maker Mindray Projects Strong Earnings Despite Instability Across The Middle East
BEIJING - Despite instability in the Middle East and North Africa, the leadership of Mindray Medical International is pressing ahead with plans to expand sales in international markets and is projecting a rise in net earnings of more than 10% in 2011